Parkinson's Institute receives $1.9 million from the California Institute for Regenerative Medicine
Published Wednesday, January 25, 2017 10:00 am

The California Institute for Regenerative Medicine has made a $1.9 million grant to the Institute for Dr. Birgitt Schuele, MD, Associate Professor, Program Director of Gene Discovery and Stem Cell Modeling to study the effects of downregulation of a key protein implicated in Parkinson’s disease as a potential novel gene therapy approach. “Alpha-synuclein has been a leading target since its discovery in 1997 as a Parkinson’s gene and the observation that alpha-synuclein is a main  neuropathological hallmark of Parkinson’s, called Lewy bodies can now be studied with this grant,” says Dr. Schuele.

<<

Send this page to a friend

Show Other Stories

2500 Hospital Drive, Bldg #10, Suite 1 | Mountain View, CA 94040
650.770.0201 main | 650.770.0204 fax (Clinic Secure)